Skip to main content

Demand: Coagulation Testing Market Revenue to Significant Growth by Top Foremost Players


 As per the study of Research Dive, coagulation testing market forecast a revenue of $3,566.0 million in the year 2026 growing at healthy CAGR of 5.9%.

Coagulation test is primarily carried out by a coagulometer that detects blood clotting time and blood's ability to clot. Consistent technological advancements in coagulation testing devices is driving the growth of the market. The growing prevalence of various blood clotting disorders, such as deep vein thrombosis (DVT), and hemophilia along with rise in aging population across the globe are the significant growth factors for the coagulation testing market. On the other hand, factors such as lack of expertise in this filed and higher costs of coagulation test devices are expected to obstruct the growth of the coagulation testing industry. Blood clot level plays a crucial role in human body as it helps in treatment of multiple diseases such as stroke, diabetes and others. IoT enabled healthcare devices have the ability of real time monitoring of blood coagulation, which helps to keep the patient’s activity under the therapeutic range with reduction of risk factor. Key advantage of this device is that it helps the patient to quickly monitor blood clots. It also lowers the risk of bleeding problems of diabetic patients. This IoT enabled application has facility to remind patients to test their clot level, which helps in reduction of risk factors. These coagulation testing market trends are anticipated to create lucrative opportunities for the growth of global coagulation testing industry.

Access to FREE Sample Report Here! @ https://www.researchdive.com/download-sample/86

Consumable type has the major share in global Coagulation Testing market; it will generate a revenue of $1,847.2 million by the end of 2026, at a CAGR of 5.6% till 2026. Coagulation Testing market size of instruments segment will generate a revenue of $1,718.8 million by 2026, increasing at a CAGR 6.3%. Remarkable advances and vast R&D efforts from manufacturers result in improvisation of reliable analyzers. This has been increasing the demand for high precision and advanced coagulation analyzers at a steady pace; these factors are expected to drive the growth of the global market. Furthermore, these analyzers are fully automated, and also can perform immunologic and chromogenic assays. These significant factors are expected to grow the global market.

Prothrombin time segment has a major share and is expected to generate a revenue of $2,475.7 million by the end of 2026, growing at a CAGR of 5.5%. Clotting time tests such as prothrombin time are majorly performed in hospital setting for perspective reason of hemostatic evaluation for multiple reasons. Moreover, Prothrombin time tests are carried out to assess the risk of thrombosis or bleeding and to monitor response to anticoagulant therapy in patients. These tests are mainly useful to diagnose and treat multiple bleeding and clotting disorders and also used to monitor the efficacy of various anticoagulants. These benefits from prothrombin time tests are estimated to spur the coagulation testing market growth. Thrombin time segment for global market shall cross $392.3 million in 2026, growing at a healthy CAGR 7.3%.

Hospitals segment has a major market share and is expected to generate a revenue of $1,290.9 million by the end of 2026, growing at a CAGR of 5.6%; this is mainly owing to massive demand for comprehensive medical care and vital innovation in therapeutic techniques. In addition, significant patient support along with affordable care for patients are making positive impacts on the growth of global market.

Point-of-Care testing will generate a revenue of $495.7 million by 2026, growing at a CAGR 6.8%. Enhancement in blood coagulation analyzers along with rising number of professionals in the development of POC (point-of-care) devices is projected to boost the growth of global market. Rising popularity for trend of self-monitoring and raised availability of POC devices for hospitals are also anticipated to fuel the demand for global market.

Speak to our Expertise before buying Report@ https://www.researchdive.com/connect-to-analyst/86

Asia-Pacific market will cross $848.7 million in 2026, increasing at a CAGR of 6.4%. The market share of this region is projected to increase at a fast rate because of massive expansion of healthcare centers and hospitals and major patient population. Moreover, market players are focusing more on the innovations in the coagulation tests and devices, for instance, Japan based company, Sysmex launched new Products called ‘Automated Blood Coagulation Analyzers CN-3000 and CN-6000’. This device offers enhanced levels of reliability and productivity, in turn responding to various customer needs and advanced quality in the field of hemostasis; these advances in technology are projected to augment the growth of Asian market.

Europe coagulation testing market share is dominant and it is expected to grow at a CAGR of 6.2% by registering a revenue of $1,094.8 million by 2026.

Europe region is focusing more on the recent innovation and excellent strategies are anticipated to drive the European Market growth. Since the past 25 years, the number of CVD (Cardiovascular disease) cases has increased in Europe mainly due to rise in the fat consumption. In addition, levels of obesity are high across Europe in both adults and children. These health issues are projected to augment the growth of market of Europe region.

Some of the leading market players are: Medtronic, Micropoint Biosciences, Helena Laboratories Corporation., Thermo Fisher Scientific Inc., Abbott., F. Hoffmann-La Roche Ltd, BD., NIHON KOHDEN CORPORATION., Sysmex Corporation, and Danaher. Significant coagulation testing companies are initiating various steps in order to strengthen their presence such as merger & acquisitions and new product development. For example, Micropoint Bioscience launched Micropoint Bioscience Point of Care Devices in which relatively small blood volume is required for coagulation monitor. To highlight on the competitive landscape analysis of multinational establishments, the porter’s five force model is discussed in the report.

Request for this Report Customization & Get 10% Discount on this Report@ https://www.researchdive.com/request-for-customization/86

Comments

Popular posts from this blog

Contactless Payment Market size share growth analysis market demand

  Contactless payment, also called as a tap-and-go system is a secure mode where the transactions are done using technologies such as NFC (near field communication), RFID (radio frequency identification), infrared, and bluetooth. Contactless payment is hassle-free and convenient for customers as it takes only one-tenth of the time taken by the old-style electronic transaction.Contactless payment is becoming popular owing to its benefits such as secure and fast payments without any need for cash or identifying details. Initially, these type of payments or cards were used for the purpose oftravelling tickets only. But today, this technology has evolved and is helping customers to make payments for almost anything. However, the permissible amount for a contactless payment varies by country and by the bank. Access to PDF Sample Report Here! @  https://www.researchdive.com/download-sample/181 Recent Developments in the Contactless Payment Industry As per a Research Dive blog,  the digital e

Covaxin vs Covishield: A Comparison between the Covid-19 Vaccines of India

  The second wave of Covid-19 pandemic has reminded people the hard times faced during the coronavirus outbreak in 2020 in India. However, there is still an upper hand in 2021 in the fight against Covid-19, and this can be attributed to the nationwide vaccination drive. It has been clear that getting vaccinated is one of the simple yet effective ways to combat the pandemic. Vaccination helps in producing antibodies and boosts the immune system to fight against any infection. Besides, getting Covid-19 vaccination is known to reduce the severity of the infection and helps in lowering the chances of getting hospitalized due to the severe infection caused due to Covid-19. Covaxin Vs Covishield Currently, the Indian Government has approved two vaccines namely Covaxin and Covishield to fight Covid-19. Many people are wondering which vaccine is better among the two, and here is a quick read to help them answer all their queries. Covaxin Covaxin was given approval for by the Indian

2-ethylhexyl Caprate Market to Incur Meteoric Growth During 2018-2026

Introduction: 2-Ethylhexyl Caprate Market 2-ethylhexyl caprate , also known as 2-ethylhexyl decanoate, is an organic chemical compound with the molecular formula C18H32O2. In the manufacturing of 2-ethylhexyl caprate, ethyl reacts with hexyl in the presence of caproic acid as a catalyst to form 2-ethylhexyl caproic acid, which on further treatment with esterification process forms a mixture of 2-ethylhexyl caprate crude. This mixture of 2-ethylhexyl caprate crude is distilled to obtain pure 2-ethylhexyl caprate. 2-ethylhexyl caprate finds several applications in chemical, pharmaceutical and textile industries as a reagent, catalyst and excipient. Along with this, 2-ethylhexyl caprate is used in the manufacturing of elastomers and coatings. On the basis of safety, 2-ethylhexyl caprate is the least harmful in the available caprate group and has low vapor pressure, which can reduce hazards while handling as compared to other caprates, such as ethylhexyl palmitate and oth